Table 1 Proportion of controls and cases with plasma that neutralized leukotoxic activity.
Men & Women | Neg | Low | High |
|---|---|---|---|
Control | 47.1% (471) | 33.3% (333) | 19.6% (196) |
Case | 45.9% (244) | 36.3% (193) | 17.9% (95) |
OR | 1.1 (0.8-1.4) | 0.9 (0.7-1.2) | |
adjusted OR | 1.0 (0.7-1.4) | 1.3 (0.9-2.0) | |
Women | Neg | Low | High |
Control | 51.7% (152) | 28.6% (84) | 19.7% (58) |
Case | 42.9% (67) | 39.7%*(62) | 17.3% (27) |
OR | 1.8* (1.1-2.8) | 1.0 (0.8-1.3) | |
adjusted OR # | 1.2 (0.5-2.9) | 1.4 (0.5-4.3) | |
Men | Neg | Low | High |
Control | 45.2% (319) | 35.3% (249) | 19.5% (138) |
Case | 47.1% (177) | 34.8% (131) | 18.1% (68) |
OR | 0.9 (0.7-1.2) | 0.8 (0.6-1.2) | |
adjusted OR # | 1.0 (0.7-1.4) | 1.3 (0.9-2.1) |